Transfer of daclatasvir and sofosbuvir's main metabolite, GS-331007, across the human placenta ex vivo

被引：2
|
作者：
Freriksen, Jolien J. M. [1 ,2 ]
Meijerhof, Miriam [1 ]
van Drongelen, Joris [3 ]
Drenth, Joost P. H. [4 ]
Burger, David M. [2 ]
Russel, Frans G. M. [1 ]
Colbers, Angela [2 ]
Greupink, Rick [1 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Pharmacol & Toxicol, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Pharm, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Obstet & Gynaecol, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Gastroenterol, Nijmegen, Netherlands
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2020年 / 223卷 / 06期
关键词：
HEPATITIS-C; PREGNANCY;
D O I：
10.1016/j.ajog.2020.08.107
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：941 / 943
页数：4
相关论文
共 50 条
  • [1] Pharmakokinetics of Daclatasvir, Sofosbuvir and GS-331007 in a Prospective Cohort of HCV Positive Kidney Transplant Recipients
    Schrezenmeier, E.
    Galander, P.
    Hoffmann, F.
    Jaeger, C.
    Lisec, J.
    Schrezenmeier, J.
    Staeck, O.
    Lehner, L.
    Khadzhynov, D.
    Halleck, F.
    Duerr, M.
    Budde, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 508 - 509
  • [2] UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients
    Notari, Stefania
    Tempestilli, Massimo
    Fabbri, Gabriele
    Libertone, Raffaella
    Antinori, Andrea
    Ammassari, Adriana
    Agrati, Chiara
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2018, 1073 : 183 - 190
  • [3] Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy
    Cusato, Jessica
    Boglione, Lucio
    De Nicolo, Amedeo
    Caviglia, Gian Paolo
    Pinna, Simone Mornese
    Ciancio, Alessia
    Troshina, Giulia
    Smedile, Antonina
    Antonucci, Miriam
    Avataneo, Valeria
    Palermiti, Alice
    Mula, Jacopo
    Manca, Alessandra
    Cariti, Giuseppe
    Cantu, Marco
    Saracco, Giorgio Maria
    Di Perri, Giovanni
    D'Avolio, Antonio
    [J]. PHARMACEUTICALS, 2022, 15 (03)
  • [4] Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS-331007 in Healthy Chinese Subjects
    Shen, Zhenwei
    Zhu, Xiaoxue
    Zhang, Hong
    Chen, Hong
    Niu, Junqi
    Chen, Guiling
    Li, Xiaojiao
    Ding, Yanhua
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (08): : 1073 - 1080
  • [5] Effect of carvedilol on pharmacokinetics of sofosbuvir and its metabolite GS-331007: role of P-glycoprotein
    Fahmy, Salma N.
    Khedr, Lobna H.
    Wahdan, Sara A.
    Menze, Esther T.
    Azab, Samar S.
    El-Demerdash, Ebtehal
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2024, 76 (08) : 1051 - 1064
  • [6] UPLC-MS/MS method for the simultaneous quantification of Ledipasvir, Sofosbuvir and its metabolite (GS-331007) in human plasma
    Baazaoui, N.
    Jebabli, N.
    Gaies, E.
    Charfi, R.
    Ben Sassi, M.
    El Jebari, H.
    Daghfous, R.
    Trabelsi, S.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 149 - 149
  • [7] Population Pharmacokinetics of Sofosbuvir and Its Major Metabolite (GS-331007) in Healthy and HCV-infected Adult Subjects
    Kirby, Brian
    Gordi, Toufigh
    Symonds, William T.
    Kearney, Brian P.
    Mathias, Anita
    [J]. HEPATOLOGY, 2013, 58 : 746A - 747A
  • [8] Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus-Positive Kidney Transplant Recipients
    Schrezenmeier, Eva
    Hoffman, Friederike
    Jaeger, Carsten
    Schrezenmeier, Jens
    Lisec, Jan
    Glander, Petra
    Algharably, Engi
    Kreutz, Reinhold
    Budde, Klemens
    Duerr, Michael
    Halleck, Fabian
    [J]. THERAPEUTIC DRUG MONITORING, 2019, 41 (01) : 53 - 58
  • [9] Quick and sensitive UPLC-ESI-MS/MS method for simultaneous quantification of sofosbuvir and its metabolite, GS-331007, in human plasma
    Semreen, Mohammad
    Alniss, Hasan
    Mousa, Muath
    Aboul-Enein, Hassan
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [10] A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study
    Ferrari, Davide
    Bagaglio, Sabrina
    Raso, Michele
    Galli, Laura
    Premaschi, Simone
    Messina, Emanuela
    Morsica, Giulia
    Locatelli, Massimo
    Uberti-Foppa, Caterina
    Hasson, Hamid
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2019, 1120 : 1 - 7
12345